Friendly bacteria reduce hospital infectionsNovember 06, 2008A probiotic bacterium, Lactobacillus plantarum 299, has been used to out-compete the dangerous bacteria that cause respiratory illness in ventilated patients. Research published in BioMed Central's open access journal Critical Care describes how applying a bacterial solution in place of normal antiseptics is effective in preventing the most common cause of ventilator-associated pneumonia (VAP). Bengt Klarin from the University Hospital in Lund, Sweden, led a team of researchers who carried out a randomised, controlled trial in fifty patients, comparing friendly bacteria to the normally used antiseptic chlorhexidine (CHX). Klarin said, "We hypothesised that swabbing the mouth with probiotics would be an effective (and microbiologically attractive) method of reducing pathogenic oral microorganisms in intubated, mechanically ventilated, critically ill patients." VAP is a common complication in patients on breathing machines. It occurs when harmful bacteria from the mouth, throat or breathing tube are inhaled into the lungs. Because most people on ventilation are sedated or unable to communicate, initial symptoms of pneumonia can be difficult to spot. According to Klarin, "VAP is connected with longer intensive care and hospital stays, additional costs and high mortality. The risk of developing this condition increases by 1% with each additional day of mechanical ventilation." The authors found that the probiotic treatment was as effective as the antiseptic. Use of the bacteria has other advantages; there are common side effects associated with CHX use in oral care, including tooth discoloration, irritation and, very occasionally, serious allergic reactions. Moreover, CHX diluted by saliva and represents an additional risk for the creation of resistant strains. The authors claim that the L. plantarum 299 solves these problems, "It is not likely to incorporate resistance genes or plasmids or to transfer genetic material. Consequently it does not contribute to the development of antibiotic-resistant strains. As the bacteria adhere to the oral mucosa, they are able to counteract potentially pathogenic bacteria around the clock, which is superior to the fairly short-term effect of orally applied chemical agents." L. plantarum is normally present in saliva and is also commonly found in fermented food products like pickles and sauerkraut. The authors found no negative side effects of using it in this study. BioMed Central |
|||||||||||||||||||||
| Related Respiratory Illness Current Events and Respiratory Illness News Articles Study raises concerns about outdoor second-hand smoke Indoor smoking bans have forced smokers at bars and restaurants onto outdoor patios, but a new University of Georgia study in collaboration with the Centers for Disease Control and Prevention suggests that these outdoor smoking areas might be creating a new health hazard. Learning the risks for stroke - and taking action With this theme in mind, the European Society of Cardiology (ESC) emphasises that most of the risks for stroke are also the major risks for coronary heart disease - and thus the object of the ESC's far-reaching prevention programme. Critical illness from 2009 H1N1 in Mexico associated with high fatality rate Critical illness from 2009 influenza A(H1N1) in Mexico occurred among young patients, was associated with severe acute respiratory distress syndrome and shock, and had a fatality rate of about 40 percent. Asthmatic children: Did mom use her pump during pregnancy? Expectant mothers who eschew asthma treatment during pregnancy heighten the risk transmitting the condition to their offspring, according to one of the largest studies of its kind published in the European Respiratory Journal. Surgical masks vs. N95 respirators for preventing influenza among health-care workers Surgical masks appear to be no worse than, and nearly as effective as N95 respirators in preventing influenza in health care workers. Guide on lung cancer in 'never-smokers': A different disease and different treatments A committee of scientists led by Johns Hopkins investigators has published a new guide to the biology, diagnosis and treatment of lung cancer in never-smokers, fortifying measures for what physicians have long known is a very different disease than in smokers. Preemies born in poverty 4 times less likely ready for school Advances in neonatal care enable two-thirds of premature babies born with respiratory problems to be ready for school at an appropriate age, but those living in poverty are far less likely to be ready on time than their better-off peers. Human nose too cold for bird flu, says new study Avian influenza viruses do not thrive in humans because the temperature inside a person's nose is too low, according to research published today in the journal PLoS Pathogens. UTSA/UTHSCSA publish results on bio-threat agent Researchers at The University of Texas at San Antonio (UTSA) South Texas Center for Emerging Infectious Diseases and The University of Texas Health Science Center at San Antonio (UTHSCSA) have identified a cell type believed to play a role in controlling the early infectious process against Francisella tularensis, a respiratory pathogen and bioterrorism agent that is the cause of tularemia. More girls than boys benefit from breastfeeding, Hopkins Children's research shows Challenging the long-standing belief that breast-feeding equally protects all babies against disease, research led by Johns Hopkins Children's Center investigators suggests that when it comes to respiratory infections, the protective effects of breast milk are higher in girls than in boys. More Respiratory Illness Current Events and Respiratory Illness News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||